Vmn1r142 Activators
Vomeronasal 1 receptor 142 activators encompass a range of compounds that, while diverse in structure, share the commonality of enhancing the receptor's signaling through various biochemical pathways. These compounds interact with multiple facets of cellular signaling, including ligand-receptor interactions, secondary messenger modulation, and enzymatic activity alterations. For instance, forskolin, by increasing intracellular cAMP, can enhance the activity of PKA, a kinase that is essential for phosphorylating proteins that vomeronasal 1 receptor 142 signaling depends upon. Similarly, IBMX works to maintainelevated cAMP levels by inhibiting the enzymes responsible for its degradation, thereby indirectly enhancing vomeronasal 1 receptor 142 activity through prolonged PKA signaling.
Chemicals such as PGE2, cholera toxin, and epinephrine exert their effects by either acting as ligands for G-protein coupled receptors or by direct enzymatic modulation to raise cAMP levels, which is a pivotal secondary messenger for PKA activation linked to vomeronasal 1 receptor 142 function. On the other hand, isoproterenol, dopamine, and histamine target specific receptors that, upon activation, stimulate adenylyl cyclase to produce cAMP, thereby facilitating an indirect enhancement of the vomeronasal 1 receptor 142 signaling cascade. PACAP and anandamide engage with their respective receptors to elevate cAMP, contributing to the activation of PKA and subsequent signaling events that enhance the function of vomeronasal 1 receptor 142. Adenosine acts similarly by targeting its own receptors to increase cAMP, thereby supporting the receptor's activity. Rolipram, by selectively inhibiting PDE4, ensures that cAMP is not rapidly degraded, which results in sustained PKA activity and thus, the enhancement of vomeronasal 1 receptor 142 signaling.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
IBMX acts as a non-specific inhibitor of phosphodiesterases, enzymes responsible for the breakdown of cAMP. By preventing cAMP degradation, IBMX can indirectly increase the activity of vomeronasal 1 receptor 142 since persistent cAMP can perpetuate PKA activity and downstream signaling related to the receptor function. | ||||||
PGE2 | 363-24-6 | sc-201225 sc-201225C sc-201225A sc-201225B | 1 mg 5 mg 10 mg 50 mg | $57.00 $159.00 $275.00 $678.00 | 37 | |
Prostaglandin E2 (PGE2) functions as a ligand for its G-protein coupled receptors, which can trigger intracellular signaling cascades involving cAMP elevation. This subsequent rise in cAMP may indirectly enhance the functional activity of vomeronasal 1 receptor 142 by sustaining PKA-mediated signaling processes. | ||||||
(−)-Epinephrine | 51-43-4 | sc-205674 sc-205674A sc-205674B sc-205674C sc-205674D | 1 g 5 g 10 g 100 g 1 kg | $41.00 $104.00 $201.00 $1774.00 $16500.00 | ||
Epinephrine interacts with adrenergic receptors which can result in the activation of adenylyl cyclase and an increase in cAMP. This elevation of cAMP can support the activity of vomeronasal 1 receptor 142 by enhancing PKA function and subsequent signal transduction processes intrinsic to the receptor. | ||||||
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
Isoproterenol is a beta-adrenergic agonist that can lead to the activation of adenylyl cyclase and a rise in cAMP levels. The increased cAMP can indirectly enhance vomeronasal 1 receptor 142 activity via the PKA signaling pathway. | ||||||
Dopamine | 51-61-6 | sc-507336 | 1 g | $290.00 | ||
Dopamine can bind to its dopamine receptors, some of which can activate adenylyl cyclase and elevate cAMP levels. This boost in cAMP can then enhance the functional activity of vomeronasal 1 receptor 142 through PKA-mediated signaling. | ||||||
Histamine, free base | 51-45-6 | sc-204000 sc-204000A sc-204000B | 1 g 5 g 25 g | $94.00 $283.00 $988.00 | 7 | |
Histamine, when bound to H2 receptors, can lead to the activation of adenylyl cyclase and increased cAMP. This cascade can indirectly enhance the activity of vomeronasal 1 receptor 142 by facilitating PKA-dependent signaling pathways. | ||||||
Adenosine | 58-61-7 | sc-291838 sc-291838A sc-291838B sc-291838C sc-291838D sc-291838E sc-291838F | 1 g 5 g 100 g 250 g 1 kg 5 kg 10 kg | $34.00 $48.00 $300.00 $572.00 $1040.00 $2601.00 $4682.00 | 1 | |
Adenosine can activate adenosine A2 receptors, which positively couple to adenylyl cyclase, leading to increased cAMP. This increment in cAMP can enhance the signaling activity of vomeronasal 1 receptor 142 through the PKA pathway. | ||||||
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $77.00 $216.00 | 18 | |
Rolipram is a selective inhibitor of phosphodiesterase 4 (PDE4), which breaks down cAMP. By inhibiting PDE4, rolipram can indirectly support the activity of vomeronasal 1 receptor 142 due to raised cAMP levels sustaining PKA signaling. | ||||||